Key terms

About ENTA

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ENTA news

May 07 11:58pm ET Hold Rating on Enanta Pharmaceuticals Amidst Clinical Trials Uncertainty and Financial Outlook by TipRanks May 07 11:35am ET Buy Rating Affirmed for Enanta Pharmaceuticals Amidst Promising RSV Developments and Clinical Trial Execution by TipRanks May 07 1:01am ET Analysts’ Top Healthcare Picks: OrthoPediatrics (KIDS), Enanta Pharmaceuticals (ENTA) by TipRanks May 07 12:51am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Enanta Pharmaceuticals (ENTA), OrthoPediatrics (KIDS) and Avanos Medical (AVNS) by TipRanks May 06 4:05pm ET Enanta reports Q2 EPS ($1.47), consensus ($1.33) by TipRanks Apr 30 7:29am ET Enanta appoints Matthew Kowalsky as chief legal officer by TipRanks Mar 12 4:13pm ET Enanta Pharmaceuticals Shareholders Affirm Management Direction by TipRanks Feb 09 8:09am ET Enanta price target lowered to $17 from $21 at Oppenheimer by TipRanks Feb 09 7:58am ET Oppenheimer Keeps Their Hold Rating on Enanta Pharmaceuticals (ENTA) by TipRanks Feb 09 12:51am ET Maintaining Hold on Enanta Pharmaceuticals Amid Near-Term Challenges and Pipeline Potential by TipRanks Feb 08 8:10am ET Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA) and Arrowhead Pharmaceuticals (ARWR) by TipRanks Feb 08 6:44am ET Enanta price target lowered to $26 from $40 at Baird by TipRanks Feb 08 12:30am ET Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Enanta Pharmaceuticals (ENTA) and Steris (STE) by TipRanks Feb 07 4:06pm ET Enanta reports Q1 EPS ($1.58), consensus ($1.22) by TipRanks

No recent press releases are available for ENTA

ENTA Financials

1-year income & revenue

Key terms

ENTA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ENTA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - MAY 03: Traders work on the floor of the New York Stock Exchange (NYSE) on May 03, 2024 in New York City. The Dow surged over 400 points in morning trading as new economic numbers showed that the central bank may cut interest rates sooner than expected. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images North America/Getty Images
There’s a surprising bit of good news lurking in the stock market
Bruce Garelick was found guilty of insider trading
John Minchillo/AP
Investor found guilty in Trump Media insider trading case
People walk toward an entrance to Disneyland in Anaheim, California on April 24, 2023.
Mario Tama/Getty Images/File
Americans are shopping less but they’re still spending on flights, hotels and Disneyland
Scaffolding and construction netting near an apartment building in New York, US, on Wednesday, Oct. 11, 2023. Monthly fees and expenses for inspections, insurance and climate-friendly upgrades are squeezing residents of the city's many co-op and condo buildings. Photographer: Michael Nagle/Bloomberg
Michael Nagle/Bloomberg/Getty Images
For US renters, the chance of owning a home is going from bad to worse